ID TYRA_STAES Reviewed; 362 AA. AC Q8CPB5; DT 03-APR-2007, integrated into UniProtKB/Swiss-Prot. DT 01-MAR-2003, sequence version 1. DT 27-MAR-2024, entry version 110. DE RecName: Full=Prephenate dehydrogenase; DE Short=PDH; DE EC=1.3.1.12; GN Name=tyrA; OrderedLocusNames=SE_1047; OS Staphylococcus epidermidis (strain ATCC 12228 / FDA PCI 1200). OC Bacteria; Bacillota; Bacilli; Bacillales; Staphylococcaceae; OC Staphylococcus. OX NCBI_TaxID=176280; RN [1] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RC STRAIN=ATCC 12228 / FDA PCI 1200; RX PubMed=12950922; DOI=10.1046/j.1365-2958.2003.03671.x; RA Zhang Y.-Q., Ren S.-X., Li H.-L., Wang Y.-X., Fu G., Yang J., Qin Z.-Q., RA Miao Y.-G., Wang W.-Y., Chen R.-S., Shen Y., Chen Z., Yuan Z.-H., RA Zhao G.-P., Qu D., Danchin A., Wen Y.-M.; RT "Genome-based analysis of virulence genes in a non-biofilm-forming RT Staphylococcus epidermidis strain (ATCC 12228)."; RL Mol. Microbiol. 49:1577-1593(2003). CC -!- CATALYTIC ACTIVITY: CC Reaction=NAD(+) + prephenate = 3-(4-hydroxyphenyl)pyruvate + CO2 + CC NADH; Xref=Rhea:RHEA:13869, ChEBI:CHEBI:16526, ChEBI:CHEBI:29934, CC ChEBI:CHEBI:36242, ChEBI:CHEBI:57540, ChEBI:CHEBI:57945; EC=1.3.1.12; CC -!- PATHWAY: Amino-acid biosynthesis; L-tyrosine biosynthesis; (4- CC hydroxyphenyl)pyruvate from prephenate (NAD(+) route): step 1/1. CC -!- SIMILARITY: Belongs to the prephenate/arogenate dehydrogenase family. CC {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AE015929; AAO04644.1; -; Genomic_DNA. DR RefSeq; NP_764602.1; NC_004461.1. DR RefSeq; WP_001831297.1; NZ_WBME01000002.1. DR AlphaFoldDB; Q8CPB5; -. DR SMR; Q8CPB5; -. DR GeneID; 50018826; -. DR KEGG; sep:SE_1047; -. DR PATRIC; fig|176280.10.peg.1023; -. DR eggNOG; COG0287; Bacteria. DR HOGENOM; CLU_055968_2_1_9; -. DR OrthoDB; 9802008at2; -. DR UniPathway; UPA00122; UER00961. DR Proteomes; UP000001411; Chromosome. DR GO; GO:0070403; F:NAD+ binding; IEA:InterPro. DR GO; GO:0008977; F:prephenate dehydrogenase (NAD+) activity; IEA:UniProtKB-EC. DR GO; GO:0004665; F:prephenate dehydrogenase (NADP+) activity; IEA:InterPro. DR GO; GO:0006571; P:tyrosine biosynthetic process; IEA:UniProtKB-UniPathway. DR Gene3D; 3.30.70.260; -; 1. DR Gene3D; 1.10.3660.10; 6-phosphogluconate dehydrogenase C-terminal like domain; 1. DR Gene3D; 3.40.50.720; NAD(P)-binding Rossmann-like Domain; 1. DR InterPro; IPR008927; 6-PGluconate_DH-like_C_sf. DR InterPro; IPR045865; ACT-like_dom_sf. DR InterPro; IPR002912; ACT_dom. DR InterPro; IPR036291; NAD(P)-bd_dom_sf. DR InterPro; IPR046825; PDH_C. DR InterPro; IPR046826; PDH_N. DR InterPro; IPR003099; Prephen_DH. DR PANTHER; PTHR21363; PREPHENATE DEHYDROGENASE; 1. DR PANTHER; PTHR21363:SF0; PREPHENATE DEHYDROGENASE [NADP(+)]; 1. DR Pfam; PF01842; ACT; 1. DR Pfam; PF20463; PDH_C; 1. DR Pfam; PF02153; PDH_N; 1. DR SUPFAM; SSF48179; 6-phosphogluconate dehydrogenase C-terminal domain-like; 1. DR SUPFAM; SSF55021; ACT-like; 1. DR SUPFAM; SSF51735; NAD(P)-binding Rossmann-fold domains; 1. DR PROSITE; PS51671; ACT; 1. DR PROSITE; PS51176; PDH_ADH; 1. PE 3: Inferred from homology; KW Amino-acid biosynthesis; Aromatic amino acid biosynthesis; NAD; KW Oxidoreductase; Tyrosine biosynthesis. FT CHAIN 1..362 FT /note="Prephenate dehydrogenase" FT /id="PRO_0000282663" FT DOMAIN 2..291 FT /note="Prephenate/arogenate dehydrogenase" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00522" FT DOMAIN 296..362 FT /note="ACT" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01007" FT BINDING 3..33 FT /ligand="NAD(+)" FT /ligand_id="ChEBI:CHEBI:57540" FT /evidence="ECO:0000255" SQ SEQUENCE 362 AA; 40710 MW; BB0D1A12046E0A3B CRC64; MRNILFVGLG LIGGSLASNL KYHYSNFNIL AYDSDYTQLD EALSIGIIDQ KVNDYATAVE IADIIIFATP VEQTIKYLSE LTNYNTKTHL IVTDTGSTKL TIQSFEKELL KHDIHLISGH PMAGSHKSGV LNAKKHLFEN AYYILVFNEI ENNEAATYLK KLLKPTLAKF IVTHANEHDF VTGIVSHVPH IIASILVHLS ANHVKDHSLI EKLAAGGFRD ITRIASSNAQ MWKDITLNNQ NHILSLLNEI KEQITGIENL IREQNSNSIY DFFVKAKDYR DQLPVKQHGA ISTAYDLYVD IPDKPGMISQ ITNIISSHNI SIINLKILEV REDIYGALQI SFKSPEDREN AIKALANFDT YY //